Back to search

Peptide record

TPDB21029

Antibacterial Anticancer Antiviral Toxicity standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB21029
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia dbAMP 3.0 DRAVP 2.0
standard
No
A 5-aa standard natural multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia, dbAMP 3.0, and DRAVP 2.0, with an available 3D structural model.
Sequence
HGVHG
Physicochemical Analysis
C21H31N9O6
ARNDCEQILKMFPSTWY
GH
505.53
8.00
2
0
1
+0
2.01
-0.600
58.00
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
2
G
2
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 2 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
5
C21H31N9O6
505.53
8.00
+0
2.01
-0.600
Evidence Records 3 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
New alloferon analogues: synthesis and antiviral properties. | Chem Biol Drug Des | 2013
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Monkey kidney epithelial cells LLC-MK2

Target

Monkey kidney epithelial cells LLC-MK2

Source & Reference

NA
DBAASP
New alloferon analogues: synthesis and antiviral properties. | Chem Biol Drug Des | 2013
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 826 µM.

Source & Reference

NA
DRAMP
Chem Biol Drug Des. 2013 Feb 81(2):302-9.